Kidney transplantation is the best possible treatment for many patients with end-stage renal
failure, but progressive dysfunction and eventual allograft loss with return to dialysis is …

Chronic allograft dysfunction is associated with a variety of fibrosing/sclerosing changes in
the allograft. Fibrosis is multifactorial, a final pathway following varying types of injury. Using …

Renal disorders account for a substantial fraction of the budget for health care in many
countries. Proteinuria is a frequent manifestation in afflicted patients, but the origin of the …

Membranous nephropathy presents clinically as nephrotic syndrome, with subepithelial
immune complex deposits seen on biopsy. Historically, in about three-quarters of …

We assessed the earliest manifestations of recurrent membranous glomerulonephritis
(MGN) in renal allografts. Clinical, laboratory and pathologic data were reviewed in 21 …

Improvements in immunosuppression have reduced acute kidney allograft rejection and
clinicians are now seeking ways to prolong allograft survival to 20 years and beyond. The …

An early lesion in many kidney diseases is damage to podocytes, which are critical
components of the glomerular filtration barrier. A number of proteins are essential for …

Abstract The 2009 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice
guideline on the monitoring, management, and treatment of kidney transplant recipients is …

Use of Rituximab in Focal Glomerulosclerosis Relapses After... : Transplantation Use of
Rituximab in Focal Glomerulosclerosis Relapses After Renal Transplantation : Transplantation …

KT is the optimal modality of treatment for patients with ESKD and, if successful, is
associated with improved quality of life, lower medical costs, and improved survival. Better …